Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

v3.19.3.a.u2
Fair Value Measurements (Tables)
6 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows:
As of December 31, 2019 (In thousands)
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant 
Other
Observable 
Inputs
(Level 2)
 
Little or No Market Activity
Inputs
(Level 3)
Assets
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
Corporate debt securities
$
857

 
$

 
$
857

 
$

Money market funds and other
435,933

 
435,933

 

 

U.S. Treasury securities
7,600

 

 
7,600

 

Marketable securities:
 
 
 
 
 
 
 
Corporate debt securities
385,179

 

 
385,179

 

Municipal securities
9,218

 

 
9,218

 

Sovereign securities
6,013

 

 
6,013

 

U.S. Government agency securities
94,776

 
94,776

 

 

U.S. Treasury securities
239,783

 
222,929

 
16,854

 

Total cash equivalents and marketable securities(1)
1,179,359

 
753,638

 
425,721

 

Other current assets:
 
 
 
 
 
 
 
Derivative assets
3,173

 

 
3,173

 

Other non-current assets:
 
 
 
 
 
 
 
Executive Deferred Savings Plan
216,612

 
166,460

 
50,152

 

Total financial assets(1)
$
1,399,144

 
$
920,098

 
$
479,046

 
$

Liabilities
 
 
 
 
 
 
 
Derivative liabilities
$
(1,759
)
 
$

 
$
(1,759
)
 
$

Deferred payments
(6,500
)
 

 

 
(6,500
)
Contingent consideration payable

(15,725
)
 

 

 
(15,725
)
Total financial liabilities
$
(23,984
)
 
$

 
$
(1,759
)
 
$
(22,225
)
________________
(1) Excludes cash of $412.5 million held in operating accounts and time deposits of $85.7 million as of December 31, 2019.

Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows:  
As of June 30, 2019 (In thousands)
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant 
Other
Observable 
Inputs
(Level 2)
 
Little or No Market Activity
Inputs
(Level 3)
Assets
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
Corporate debt securities
$
10,988

 
$

 
$
10,988

 
$

Money market funds and other
352,708

 
352,708

 

 

U.S. Government agency securities
27,994

 

 
27,994

 

U.S. Treasury securities
55,858

 

 
55,858

 

Marketable securities:
 
 
 
 
 
 
 
Corporate debt securities
422,089

 

 
422,089

 

Municipal securities
1,913

 

 
1,913

 

Sovereign securities
5,994

 

 
5,994

 

U.S. Government agency securities
131,224

 
131,224

 

 

U.S. Treasury securities
151,838

 
151,838

 

 

Total cash equivalents and marketable securities(1)
1,160,606

 
635,770

 
524,836

 

Other current assets:
 
 
 
 
 
 
 
Derivative assets
2,557

 

 
2,557

 

Other non-current assets:
 
 
 
 
 
 
 
Executive Deferred Savings Plan
207,581

 
158,021

 
49,560

 

Total financial assets(1)
$
1,370,744

 
$
793,791

 
$
576,953

 
$

Liabilities
 
 
 
 
 
 
 
Derivative liabilities
$
(3,334
)
 
$

 
$
(3,334
)
 
$

Deferred payments
(8,800
)
 

 

 
(8,800
)
Contingent consideration payable
(14,005
)
 

 

 
(14,005
)
Total financial liabilities
$
(26,139
)
 
$

 
$
(3,334
)
 
$
(22,805
)
________________
(1) Excludes cash of $479.8 million held in operating accounts and time deposits of $99.0 million as of June 30, 2019.